Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9.

MLA

Alkindi, Manal, et al. “Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9.” The Canadian Journal of Cardiology, vol. 32, no. 12, Dec. 2016, pp. 1552–60. EBSCOhost, https://doi.org/10.1016/j.cjca.2016.04.013.

APA

Alkindi, M., Siminovitch, K. A., Gupta, M., & Genest, J. (2016). Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9. The Canadian Journal of Cardiology, 32(12), 1552–1560. https://doi.org/10.1016/j.cjca.2016.04.013

Chicago

Alkindi, Manal, Katherine A Siminovitch, Milan Gupta, and Jacques Genest. 2016. “Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9.” The Canadian Journal of Cardiology 32 (12): 1552–60. doi:10.1016/j.cjca.2016.04.013.